Pigmented villonodular synovitis (PVNS) confirmed at two or more distinct joint sites simultaneously, classified under other and unspecified arthropathy in Chapter 13.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 11
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M12.29.
Source · Editorial brief grounded in 5 cited references ↓
- Name every affected joint explicitly in the clinical note — 'right knee and left hip' is sufficient; 'multiple joints' alone is not specific enough for confident code assignment.
- Distinguish multi-site PVNS (two different joint types) from bilateral PVNS of the same joint type; the latter codes to the unspecified-laterality single-site code, not M12.29.
- Include MRI or arthroscopic findings that confirm synovial involvement at each site — hemosiderin deposition, villous hypertrophy, or the classic 'blooming artifact' on gradient-echo sequences supports the PVNS diagnosis.
- Document prior treatment history (prior synovectomy, radiation synovectomy) at each site if recurrence is being coded; this supports medical necessity for revision procedures.
- If pathology is pending, query the physician before finalizing M12.29 — PVNS requires histologic or strong imaging confirmation; don't code from suspicion alone.
Related CPT procedures
Procedure codes commonly billed with M12.29. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M12.29 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Using M12.29 for bilateral involvement of the same joint (e.g., both knees) — that scenario codes to the single-site unspecified-laterality code such as M12.269, not M12.29.
- Defaulting to M12.29 when only one joint is documented because 'PVNS commonly recurs' — code only what is confirmed and documented at the current encounter.
- Confusing M12.28 (other specified single site) with M12.29 (multiple sites) — M12.28 applies when one involved joint isn't listed among the specific child codes, not when there are multiple joints.
- Failing to code each relevant procedure CPT separately when surgery addresses more than one joint in the same operative session, which can trigger bundling edits if the diagnosis doesn't clearly support multi-site disease.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M12.29 applies when pigmented villonodular synovitis is documented at multiple joint locations in the same patient — for example, concurrent PVNS affecting the knee and hip, or the knee and ankle. If involvement is confined to a single joint, drop to the site-specific code within M12.2x (e.g., M12.261 for right knee PVNS). M12.28 covers a single joint not listed elsewhere in the category; M12.29 is reserved for genuinely multi-site disease.
PVNS is a locally aggressive, benign synovial proliferative disorder characterized by hemosiderin-laden synovium, villous or nodular growth patterns, and recurrent hemarthrosis. Multi-site presentation is uncommon; the clinician's note must explicitly document involvement at more than one joint — not merely bilateral involvement of the same joint type (which would still code to the unspecified-laterality child code for that joint) — before M12.29 is appropriate.
This code carries no 7th-character extension requirement. It sits under parent M12.2 (Villonodular synovitis, pigmented), which is non-billable; M12.29 itself is the billable endpoint. Payers may scrutinize M12.29 claims for multi-site documentation; ensure the operative or diagnostic note names each affected joint.
Sibling codes
Other billable codes under M12.2 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01When does PVNS in both knees code to M12.29 versus M12.269?
02Is M12.29 valid if PVNS at one site is active and the other site is in remission?
03Can M12.29 be used for a diffuse-type PVNS that involves the entire joint capsule of one knee?
04Does M12.29 require a 7th-character extension?
05What imaging supports M12.29 in an audit?
06Which M12.2x code should I use if a patient has PVNS in the right shoulder and right wrist?
07Is M12.29 a valid primary diagnosis for surgical synovectomy claims?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 — https://icd10cmtool.cdc.gov/
- 02ICD10data.com 2026 ICD-10-CM Diagnosis Code M12.29 — https://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M12-/M12.29
- 03ICD-10-CM Official Guidelines for Coding and Reporting FY2025 — https://ftp.cdc.gov/pub/health_statistics/nchs/publications/ICD10CM/2025-Update/ICD-10-CM-April-1-FY25-Guidelines.pdf
- 04AAPC Codify — https://www.aapc.com/codes/icd-10-codes/M12.29
- 05NIH VSAC Code Browser M12.29 — https://vsac.nlm.nih.gov/context/cs/codesystem/ICD10CM/version/2023/code/M12.29/info
Mira AI Scribe
Mira AI Scribe captures the joint names and sides for each site of PVNS involvement, MRI or arthroscopic findings (synovial thickening, hemosiderin, blooming artifact) at each location, and any prior synovectomy history — preventing a generic 'multiple joints' note that leaves coders unable to validate M12.29 over a single-site code and risking a medical-necessity denial.
See how Mira captures M12.29 documentation